Pharmacoepidemiological analysis of the use of bronchodilators in bronchial asthma (BA) treatment in Russia Source: Eur Respir J 2007; 30: Suppl. 51, 154s Year: 2007
Pharmacoepidemiological analysis of the treatment of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study Source: Eur Respir J 2006; 28: Suppl. 50, 313s Year: 2006
Asthma control test (ACT) in outpatients and hospitalized patients with bronchial asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Cost-effectivness of transition to new strategy of treatment in patients with bronchial asthma (BA) in Russia Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001
Pharma-epidemiology of bronchial asthma (BA) in Russia. The results of the program ²BASIS². Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Respiratory training as a method of psychological rahabilitation for bronchial asthma (BA) patients Source: Eur Respir J 2005; 26: Suppl. 49, 311s Year: 2005
Practice-related treatment of severe persistent bronchial asthma using omalizumab in Germany: the compliance and utilisation investigation under real-life-study (XCLUSIVE) Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Cost-effectiveness of transition to new strategy of treatment in patients with bronchial asthma (BA) in Russia Source: Eur Respir J 2002; 20: Suppl. 38, 56s Year: 2002
Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007
Bronchophonographia (BPG) in evaluation of lung function in children with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003
Efficacy of the using budesonide/formoterol in patients with bronchial asthma (BA): the study of routine clinical practice Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006
The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008
The level of asthma control in patients with asthma in primary care in Sweden. Results from the AIM-study (asthma in middle Sweden) Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002
Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015
Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Absence of nonspecific bronchial responsiveness (NSBR) in occupational asthma (OA): A case-series study Source: Annual Congress 2012 - Occupational asthma Year: 2012
Differences in asthma outpatient therapy - data from the EGEA study Source: Eur Respir J 2003; 22: Suppl. 45, 296s Year: 2003
Airway remodelling augmented in patients with asthma COPD overlap (ACO) compared to asthma and COPD. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021